FOR IMMEDIATE RELEASE: KINDERHOOK, N.Y. -- April 29, 2024 -- American Bio Medica Corporation (NASDAQ: ABMC), will release its first quarter earnings on Wednesday, April 30, 2024 after trading ends on the Nasdaq Stock Market. The Company will also host a conference call on Thursday, May 1, 2003, at 8:30 a.m. EST to discuss the first quarter results and business outlook. Investors and interested parties are invited to participate. The call will be broadcast live over the internet at www.abmc.com/investor/. The webcast will be listen-only mode. Listeners are requested to be online at least fifteen minutes early to register, as well as to download and install any complimentary audio software that might be required. To ask questions, you are invited to participate by phone. Within the United States, dial 1-800-360-9865 and internationally dial 973-694-6836. The call will be available for replay on the Company's website at www.abmc.com/investor/ for 30 days. About American Bio Medica Corporation American Bio Medica Corporation develops, manufactures and markets
inexpensive, accurate, onsite drugs-of-abuse diagnostic kits and
support services worldwide. The Company and its worldwide distribution
network target the workplace, government, corrections, clinical and
educational markets. ABMC's Rapid Drug Screen®, Rapid One® Rapid
Tec® and Rapid Tec Cup test for the presence or absence of drugs
of abuse in urine, while its OralStat6® tests for the presence or
absence of drugs of abuse in saliva. ABMC was recently named among the
2002 Deloitte & Touche Technology Fast 500, a listing of the
fastest-growing technology companies in North America.
Contact: American Bio Medica Corporation Gerald A. Moore, 800/227-1243 gmoore@abmc.com
|